216 related articles for article (PubMed ID: 22058295)
1. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
Jameson SS; Charman SC; Gregg PJ; Reed MR; van der Meulen JH
J Bone Joint Surg Br; 2011 Nov; 93(11):1465-70. PubMed ID: 22058295
[TBL] [Abstract][Full Text] [Related]
2. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
6. Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11,459 patients.
Ogonda L; Hill J; Doran E; Dennison J; Stevenson M; Beverland D
Bone Joint J; 2016 Mar; 98-B(3):341-8. PubMed ID: 26920959
[TBL] [Abstract][Full Text] [Related]
7. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb.
Jameson SS; Bottle A; Malviya A; Muller SD; Reed MR
J Bone Joint Surg Br; 2010 Jan; 92(1):123-9. PubMed ID: 20044690
[TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
9. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
Ghosh A; Best AJ; Rudge SJ; Chatterji U
J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
[TBL] [Abstract][Full Text] [Related]
11. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
12. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
13. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
14. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
16. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism.
Marchena PJ; Nieto JA; Guil M; García-Bragado F; Rabuñal R; Boccalon H; Trujillo-Santos J; Monreal M;
Thromb Haemost; 2012 Jan; 107(1):37-43. PubMed ID: 22116496
[TBL] [Abstract][Full Text] [Related]
17. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
18. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.
Intermountain Joint Replacement Center Writing Committee
J Arthroplasty; 2012 Jan; 27(1):1-9.e2. PubMed ID: 21621959
[TBL] [Abstract][Full Text] [Related]
20. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.
Cusick LA; Beverland DE
J Bone Joint Surg Br; 2009 May; 91(5):645-8. PubMed ID: 19407300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]